BIOLASE Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $3.4
- Today's High:
- $3.76
- Open Price:
- $3.55
- 52W Low:
- $0.0638
- 52W High:
- $5.94
- Prev. Close:
- $3.72
- Volume:
- 192261
Company Statistics
- Market Cap.:
- $2.54 million
- Book Value:
- 0.31
- Revenue TTM:
- $48.76 million
- Operating Margin TTM:
- -54.19%
- Gross Profit TTM:
- $16.53 million
- Profit Margin:
- -60.92%
- Return on Assets TTM:
- -35.83%
- Return on Equity TTM:
- -206.6%
Company Profile
BIOLASE Inc had its IPO on 1992-11-13 under the ticker symbol BIOL.
The company operates in the Healthcare sector and Medical Devices industry. BIOLASE Inc has a staff strength of 188 employees.
Stock update
Shares of BIOLASE Inc opened at $3.55 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $3.4 - $3.76, and closed at $3.56.
This is a -4.3% slip from the previous day's closing price.
A total volume of 192,261 shares were traded at the close of the day’s session.
In the last one week, shares of BIOLASE Inc have slipped by -12.96%.
BIOLASE Inc's Key Ratios
BIOLASE Inc has a market cap of $2.54 million, indicating a price to book ratio of 0.3377 and a price to sales ratio of 0.1019.
In the last 12-months BIOLASE Inc’s revenue was $48.76 million with a gross profit of $16.53 million and an EBITDA of $-25894000. The EBITDA ratio measures BIOLASE Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, BIOLASE Inc’s operating margin was -54.19% while its return on assets stood at -35.83% with a return of equity of -206.6%.
In Q1, BIOLASE Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 3%.
BIOLASE Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- -0.22
Its diluted EPS in the last 12-months stands at $-3.85 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -0.22. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BIOLASE Inc’s profitability.
BIOLASE Inc stock is trading at a EV to sales ratio of 0.2041 and a EV to EBITDA ratio of -0.4407. Its price to sales ratio in the trailing 12-months stood at 0.1019.
BIOLASE Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $41.94 million
- Total Liabilities
- $19.00 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $587000
- Dividend Payout Ratio
- 0%
BIOLASE Inc ended 2024 with $41.94 million in total assets and $0 in total liabilities. Its intangible assets were valued at $41.94 million while shareholder equity stood at $8.16 million.
BIOLASE Inc ended 2024 with $0 in deferred long-term liabilities, $19.00 million in other current liabilities, 26000.00 in common stock, $-302017000.00 in retained earnings and $2.93 million in goodwill. Its cash balance stood at $6.53 million and cash and short-term investments were $6.53 million. The company’s total short-term debt was $2,171,000 while long-term debt stood at $12.50 million.
BIOLASE Inc’s total current assets stands at $31.96 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $5.16 million compared to accounts payable of $7.54 million and inventory worth $17.78 million.
In 2024, BIOLASE Inc's operating cash flow was $0 while its capital expenditure stood at $587000.
Comparatively, BIOLASE Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $3.56
- 52-Week High
- $5.94
- 52-Week Low
- $0.0638
- Analyst Target Price
- $3.88
BIOLASE Inc stock is currently trading at $3.56 per share. It touched a 52-week high of $5.94 and a 52-week low of $5.94. Analysts tracking the stock have a 12-month average target price of $3.88.
Its 50-day moving average was $6.16 and 200-day moving average was $31.55 The short ratio stood at 0.28 indicating a short percent outstanding of 0%.
Around 1547.1% of the company’s stock are held by insiders while 1297.8% are held by institutions.
Frequently Asked Questions About BIOLASE Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.